These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35339450)

  • 1. Urinary metabolomics identified metabolic disturbance associated with polycystic ovary syndrome.
    Yang Z; Cai X; Xu X; Xu Z; Ye S; Wang Y; Hong Y; Shen B; Liao Q; Xie Z; Wang X
    Anal Biochem; 2022 Jun; 647():114665. PubMed ID: 35339450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal Activation of Tryptophan-Kynurenine Pathway in Women With Polycystic Ovary Syndrome.
    Wang S; Mu L; Zhang C; Long X; Zhang Y; Li R; Zhao Y; Qiao J
    Front Endocrinol (Lausanne); 2022; 13():877807. PubMed ID: 35721725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolomics and correlation network analysis of follicular fluid reveals associations between l-tryptophan, l-tyrosine and polycystic ovary syndrome.
    Hou E; Zhao Y; Hang J; Qiao J
    Biomed Chromatogr; 2021 Mar; 35(3):e4993. PubMed ID: 32986877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining a nontargeted and targeted metabolomics approach to identify metabolic pathways significantly altered in polycystic ovary syndrome.
    Chang AY; Lalia AZ; Jenkins GD; Dutta T; Carter RE; Singh RJ; Nair KS
    Metabolism; 2017 Jun; 71():52-63. PubMed ID: 28521878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-invasive urinary metabolomics reveals metabolic profiling of polycystic ovary syndrome and its subtypes.
    Zhou W; Hong Y; Yin A; Liu S; Chen M; Lv X; Nie X; Tan N; Zhang Z
    J Pharm Biomed Anal; 2020 Jun; 185():113262. PubMed ID: 32222648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of the tryptophan metabolome in urine of patients with acute intermittent porphyria.
    Gomez-Gomez A; Marcos J; Aguilera P; To-Figueras J; Pozo OJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():347-354. PubMed ID: 28666226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum metabolomics analysis of patients with polycystic ovary syndrome by mass spectrometry.
    Jia C; Xu H; Xu Y; Xu Y; Shi Q
    Mol Reprod Dev; 2019 Mar; 86(3):292-297. PubMed ID: 30624822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolomics in polycystic ovary syndrome.
    Murri M; Insenser M; Escobar-Morreale HF
    Clin Chim Acta; 2014 Feb; 429():181-8. PubMed ID: 24368231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomic Profiling of Pregnancies With Polycystic Ovary Syndrome Identifies a Unique Metabolic Signature and Potential Predictive Biomarkers of Low Birth Weight.
    Diboun I; Ramanjaneya M; Ahmed L; Bashir M; Butler AE; Albagha O; Abou-Samra AB; Atkin SL; Mazloum NA; Elrayess MA
    Front Endocrinol (Lausanne); 2021; 12():638727. PubMed ID: 34211435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum metabolomics study of polycystic ovary syndrome based on UPLC-QTOF-MS coupled with a pattern recognition approach.
    Dong F; Deng D; Chen H; Cheng W; Li Q; Luo R; Ding S
    Anal Bioanal Chem; 2015 Jun; 407(16):4683-95. PubMed ID: 25860656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMR Metabolomics Show Evidence for Mitochondrial Oxidative Stress in a Mouse Model of Polycystic Ovary Syndrome.
    Selen ES; Bolandnazar Z; Tonelli M; Bütz DE; Haviland JA; Porter WP; Assadi-Porter FM
    J Proteome Res; 2015 Aug; 14(8):3284-91. PubMed ID: 26076986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated metabolomics and network pharmacology to reveal the therapeutic mechanism of Dingkun Pill on polycystic ovary syndrome.
    Cai YL; Zhang F; Dou XX; Zeng HW; Wu GS; Liang YL; Xu XK; Zhao J; Ye J; Zhang WD
    J Ethnopharmacol; 2022 Sep; 295():115442. PubMed ID: 35688255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic profiles characterizing different phenotypes of polycystic ovary syndrome: plasma metabolomics analysis.
    Zhao Y; Fu L; Li R; Wang LN; Yang Y; Liu NN; Zhang CM; Wang Y; Liu P; Tu BB; Zhang X; Qiao J
    BMC Med; 2012 Nov; 10():153. PubMed ID: 23198915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UHPLC/Q-TOFMS-based plasma metabolomics of polycystic ovary syndrome patients with and without insulin resistance.
    Chen YX; Zhang XJ; Huang J; Zhou SJ; Liu F; Jiang LL; Chen M; Wan JB; Yang DZ
    J Pharm Biomed Anal; 2016 Mar; 121():141-150. PubMed ID: 26808063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of potential metabolic biomarkers of polycystic ovary syndrome in follicular fluid by SWATH mass spectrometry.
    Sun Z; Chang HM; Wang A; Song J; Zhang X; Guo J; Leung PCK; Lian F
    Reprod Biol Endocrinol; 2019 Jun; 17(1):45. PubMed ID: 31186025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amino acid and fatty acid metabolomic profile during fasting and hyperinsulinemia in girls with polycystic ovarian syndrome.
    Cree-Green M; Carreau AM; Rahat H; Garcia-Reyes Y; Bergman BC; Pyle L; Nadeau KJ
    Am J Physiol Endocrinol Metab; 2019 May; 316(5):E707-E718. PubMed ID: 30753112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Untargeted metabolomic approach to study the serum metabolites in women with polycystic ovary syndrome.
    Yu Y; Tan P; Zhuang Z; Wang Z; Zhu L; Qiu R; Xu H
    BMC Med Genomics; 2021 Aug; 14(1):206. PubMed ID: 34416878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of Oligopin Supplementation on Hormonal and Metabolic Profiles in the Polycystic Ovary Syndrome: A Randomized Controlled Trial.
    Qorbani M; Sanginabadi M; Mohajeri-Tehrani MR; Karimi S; Gerami H; Mahdavi-Gorabi A; Shirzad N; Samadi M; Baygi F; Hosseini S; Mansour A
    Front Endocrinol (Lausanne); 2020; 11():590392. PubMed ID: 33408691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum metabolomics of Indian women with polycystic ovary syndrome using
    RoyChoudhury S; Mishra BP; Khan T; Chattopadhayay R; Lodh I; Datta Ray C; Bose G; Sarkar HS; Srivastava S; Joshi MV; Chakravarty B; Chaudhury K
    Mol Biosyst; 2016 Oct; 12(11):3407-3416. PubMed ID: 27714060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic alterations associated with polycystic ovary syndrome: A UPLC Q-Exactive based metabolomic study.
    Chen X; Lu T; Wang X; Sun X; Zhang J; Zhou K; Ji X; Sun R; Wang X; Chen M; Ling X
    Clin Chim Acta; 2020 Mar; 502():280-286. PubMed ID: 31758934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.